N-terminal pro-brain natriuretic peptide in essential arterial hypertension patients: antihypertensive therapy effects

The authors studied N-terminal pro-brain natriuretic peptide (N-proBNP) role in 43 essential arterial hypertension (EAH) patients, as well as antihypertensive therapy effects on N-proBNP. N-proBNP levels were independent of gender or age. ACE inhibitor spirapril significantly decreased N-proBNP leve...

Full description

Saved in:
Bibliographic Details
Main Authors: A. S. Galyavich, E. R. Valiullina
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2006-10-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/1975
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849690867448676352
author A. S. Galyavich
E. R. Valiullina
author_facet A. S. Galyavich
E. R. Valiullina
author_sort A. S. Galyavich
collection DOAJ
description The authors studied N-terminal pro-brain natriuretic peptide (N-proBNP) role in 43 essential arterial hypertension (EAH) patients, as well as antihypertensive therapy effects on N-proBNP. N-proBNP levels were independent of gender or age. ACE inhibitor spirapril significantly decreased N-proBNP level, while calcium antagonist nifedipine and beta-adrenoblocker metoprolol did not affect it.
format Article
id doaj-art-792ea49caa434e549247028b633392d4
institution DOAJ
issn 1560-4071
2618-7620
language Russian
publishDate 2006-10-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj-art-792ea49caa434e549247028b633392d42025-08-20T03:21:12Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202006-10-010576811732N-terminal pro-brain natriuretic peptide in essential arterial hypertension patients: antihypertensive therapy effectsA. S. Galyavich0E. R. Valiullina1Казанский государственный медицинский университет, городская клиническая больница № 18 г. КазаниКазанский государственный медицинский университет, городская клиническая больница № 18 г. КазаниThe authors studied N-terminal pro-brain natriuretic peptide (N-proBNP) role in 43 essential arterial hypertension (EAH) patients, as well as antihypertensive therapy effects on N-proBNP. N-proBNP levels were independent of gender or age. ACE inhibitor spirapril significantly decreased N-proBNP level, while calcium antagonist nifedipine and beta-adrenoblocker metoprolol did not affect it.https://russjcardiol.elpub.ru/jour/article/view/1975nfterminal profbrain natriuretic peptidearterial hypertensionspirapril
spellingShingle A. S. Galyavich
E. R. Valiullina
N-terminal pro-brain natriuretic peptide in essential arterial hypertension patients: antihypertensive therapy effects
Российский кардиологический журнал
nfterminal profbrain natriuretic peptide
arterial hypertension
spirapril
title N-terminal pro-brain natriuretic peptide in essential arterial hypertension patients: antihypertensive therapy effects
title_full N-terminal pro-brain natriuretic peptide in essential arterial hypertension patients: antihypertensive therapy effects
title_fullStr N-terminal pro-brain natriuretic peptide in essential arterial hypertension patients: antihypertensive therapy effects
title_full_unstemmed N-terminal pro-brain natriuretic peptide in essential arterial hypertension patients: antihypertensive therapy effects
title_short N-terminal pro-brain natriuretic peptide in essential arterial hypertension patients: antihypertensive therapy effects
title_sort n terminal pro brain natriuretic peptide in essential arterial hypertension patients antihypertensive therapy effects
topic nfterminal profbrain natriuretic peptide
arterial hypertension
spirapril
url https://russjcardiol.elpub.ru/jour/article/view/1975
work_keys_str_mv AT asgalyavich nterminalprobrainnatriureticpeptideinessentialarterialhypertensionpatientsantihypertensivetherapyeffects
AT ervaliullina nterminalprobrainnatriureticpeptideinessentialarterialhypertensionpatientsantihypertensivetherapyeffects